Jens Köhler

4.2k total citations
45 papers, 1.3k citations indexed

About

Jens Köhler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jens Köhler has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jens Köhler's work include Lung Cancer Treatments and Mutations (13 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Jens Köhler is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Jens Köhler collaborates with scholars based in Germany, United States and China. Jens Köhler's co-authors include Martin Schüler, Felix Nensa, Philipp Heusch, Ivo Steinmetz, Katrin Breitbach, Henning Reis, Christian Buchbender, Benedikt Gomez, Haiyun Wang and Thomas Gauler and has published in prestigious journals such as Cell, PLoS ONE and Cancer Research.

In The Last Decade

Jens Köhler

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jens Köhler Germany	22	398	397	304	302	147	45	1.3k
Jon Strasser United States	12	392 1.0×	167 0.4×	228 0.8×	316 1.0×	82 0.6×	25	1.2k
Thomas Hager Germany	21	339 0.9×	529 1.3×	371 1.2×	89 0.3×	81 0.6×	70	1.2k
Clément Bailly France	22	229 0.6×	219 0.6×	333 1.1×	528 1.7×	82 0.6×	74	1.1k
Óscar Gallego Spain	19	282 0.7×	266 0.7×	281 0.9×	83 0.3×	112 0.8×	68	1.3k
Ho Sup Lee South Korea	20	385 1.0×	151 0.4×	371 1.2×	172 0.6×	75 0.5×	117	1.6k
Ryo Tanaka Japan	14	210 0.5×	308 0.8×	411 1.4×	105 0.3×	61 0.4×	51	956
Hans J. Altermatt Switzerland	19	442 1.1×	334 0.8×	564 1.9×	126 0.4×	191 1.3×	30	1.5k
Wei‐Hsin Lin Taiwan	16	310 0.8×	271 0.7×	326 1.1×	121 0.4×	67 0.5×	40	1.0k
Huaijun Wang Belgium	20	394 1.0×	110 0.3×	416 1.4×	408 1.4×	103 0.7×	45	1.2k
Rafael Malagoli Rocha Brazil	23	580 1.5×	369 0.9×	482 1.6×	82 0.3×	248 1.7×	71	1.5k

Countries citing papers authored by Jens Köhler

Since Specialization

Citations

This map shows the geographic impact of Jens Köhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Köhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Köhler more than expected).

Fields of papers citing papers by Jens Köhler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Köhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Köhler. The network helps show where Jens Köhler may publish in the future.

Co-authorship network of co-authors of Jens Köhler

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Köhler. A scholar is included among the top collaborators of Jens Köhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Köhler. Jens Köhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boch, Tobias, Jens Köhler, Melanie Janning, & Sonja Loges. (2022). Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives. Cancer Biology and Medicine. 19(11). 1543–1564. 21 indexed citations

Dai, Yao, et al.. (2021). Unbiased RNA-Seq-driven identification and validation of reference genes for quantitative RT-PCR analyses of pooled cancer exosomes. BMC Genomics. 22(1). 27–27. 27 indexed citations

Wang, Haiyun, Qi Lv, Yue Xu, et al.. (2019). An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. 49. 106–117. 21 indexed citations

Wang, Haiyun, Qi Lv, Yue Xu, et al.. (2019). An Integrative Pharmacogenomics Analysis Identifies Therapeutic Targets in KRAS-Mutant Lung Cancer. SSRN Electronic Journal. 1 indexed citations

Ambrogio, Chiara, Jens Köhler, Zhi Zhou, et al.. (2017). P3.02-066 Wild-Type KRAS Mediates Growth Inhibition and Resistance to MEK Inhibitors through Dimerization with Mutant KRAS in Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(11). S2261–S2261. 1 indexed citations

Ambrogio, Chiara, Jens Köhler, Zhi Zhou, et al.. (2017). Wild-type KRAS mediates growth inhibition and resistance to MEK inhibitors through dimerization with mutant KRAS in lung adenocarcinoma. Annals of Oncology. 28. v1–v1. 3 indexed citations

Köhler, Jens. (2017). Second-Line Treatment of NSCLC—The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms. Frontiers in Medicine. 4. 9–9. 11 indexed citations

Schaarschmidt, Benedikt M., Christian Buchbender, Felix Nensa, et al.. (2015). Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI. PLoS ONE. 10(1). e0116277–e0116277. 34 indexed citations

Schaarschmidt, Benedikt M., Christian Buchbender, Benedikt Gomez, et al.. (2015). Thoracic staging of non-small-cell lung cancer using integrated 18F-FDG PET/MR imaging: diagnostic value of different MR sequences. European Journal of Nuclear Medicine and Molecular Imaging. 42(8). 1257–1267. 15 indexed citations

10.

Heusch, Philipp, Christian Buchbender, Jens Köhler, et al.. (2014). Thoracic Staging in Lung Cancer: Prospective Comparison of ¹⁸F-FDG PET/MR Imaging and ¹⁸F-FDG PET/CT. Journal of Nuclear Medicine. 55(3). 373–378. 88 indexed citations

11.

Heusch, Philipp, Felix Nensa, Benedikt M. Schaarschmidt, et al.. (2014). Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology. European Journal of Nuclear Medicine and Molecular Imaging. 42(1). 42–48. 52 indexed citations

12.

Breitenbuecher, Frank, S Hoffarth, Karl Worm, et al.. (2014). Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients. PLoS ONE. 9(1). e85350–e85350. 50 indexed citations

13.

Yang, James Chih‐Hsin, Noemı́ Reguart, Jana Barinoff, et al.. (2013). Diarrhea associated with afatinib: an oral ErbB family blocker. Expert Review of Anticancer Therapy. 13(6). 729–736. 88 indexed citations

14.

Heusch, Philipp, Jens Köhler, Hans-Joerg Wittsack, et al.. (2013). Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): Preliminary results in non-small cell lung cancer (NSCLC). European Journal of Radiology. 82(11). 2055–2060. 26 indexed citations

15.

Heusch, Philipp, Jens Köhler, Felix Nensa, et al.. (2013). Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Hybrid 18F-FDG PET/MRI in Non-Small Cell Lung Cancer (NSCLC) Lesions: Initial Results. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 185(11). 1056–1062. 38 indexed citations

16.

Köhler, Jens, Karl Worm, Thomas Gauler, et al.. (2012). Impact of EGFR Mutation Status on Clinical Benefit from BIBW 2992 in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC) Progressing After Chemotherapy (CTX) and Erlotinib (E) or Gefitinib (G) – A Single Center Experience. Annals of Oncology. 23. ix437–ix438. 1 indexed citations

17.

Breitbach, Katrin, et al.. (2009). Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. Journal of Immunological Methods. 342(1-2). 13–19. 32 indexed citations

18.

Breitbach, Katrin, Jens Köhler, & Ivo Steinmetz. (2008). Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102. S89–S94. 44 indexed citations

19.

Gebhardt, Carl, Jens Köhler, & Christian Jurowich. (2003). Pankreaskopfkarzinom, Papillenkarzinom, Zystadenokarzinom -Unterschiedliche Entitäten und unterschiedliche Ergebnisse. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 128(5). 396–400. 1 indexed citations

20.

Meyer, W., Jens Köhler, & C Gebhardt. (1999). Cystic neoplasms of the pancreas - cystadenomas and cystadenocarcinomas. Langenbeck s Archives of Surgery. 384(1). 44–49. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact